Pulmonális artériás hipertónia: vizsgálatok itt: Spanyolország
28 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 16.. Ask the study team whether a trial fits you.
- 1/2. fázisTaking peopleA Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
- Where
- Barcelona, Huelva, Las Palmas de Gran Canaria, Málaga, Marbella, Santiago de Compostela, Sevilla, Toledo
- Életkor
- 18 év and over
- People
- 85 worldwide
- Run by
- Novartis Pharma AG
See details and how to join2024-513613-12-00 - 1/2. fázisTaking peoplePhase 1b/2 Dose-Ranging Study of the Safety, PK, PD & Efficacy of the Activin Signaling Inhibitor HS235 vs placebo added to background therapy in PAH (SEASIde)
- Where
- Barcelona, Madrid, Marbella, Salamanca, Santander, Sevilla, Toledo
- Életkor
- 18 év and over
- People
- 50 worldwide
- Run by
- 35Pharma Inc.
See details and how to join2025-523010-89-00 - 3. fázisTaking peopleAn Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Where
- Madrid
- Életkor
- 18 év and over
- People
- 344 worldwide
- Run by
- Insmed Incorporated
See details and how to joinNCT07234032 · EU 2025-521769-29-00 - No phaseNot yet taking people in SpanyolországHome-based Inspiratory Muscle Training in Pulmonary Hypertension
- Where
- Madrid
- Életkor
- 18 év and over
- People
- 40
- Run by
- Universidad Complutense de Madrid
See details and how to joinNCT07917416 - 3. fázisNot yet taking people in SpanyolországA Study Providing Treatment Access in Participants With Pulmonary Hypertension Completing a Parent Study and Having no Other Option
- Where
- Madrid
- Életkor
- 2 év and over
- People
- 280 worldwide
- Run by
- Actelion
See details and how to joinNCT05179876 · EU 2023-506791-27-00 - 2. fázisTaking peopleStudy to Evaluate Sotatercept (MK-7962) in Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-008)
- Where
- Barcelona, Madrid, Valencia
- Életkor
- 1 év to 17 év
- People
- 42 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT05587712 · EU 2023-504861-22-00 - 1/2. fázisTaking peopleA Study of HS235 for Treatment of Pulmonary Arterial Hypertension (PAH) in Adults
- Where
- Barcelona, Madrid
- Életkor
- 18 év and over
- People
- 90 worldwide
- Run by
- 35Pharma Inc., a GSK company
See details and how to joinNCT07143448 - 4. fázisTaking peopleInitial Triple Therapy Including Parenteral Treprostinil vs Initial Double Oral Therapy in PAH Group I Patients
- Where
- Barcelona, Madrid
- Életkor
- 18 év to 75 év
- People
- 110 worldwide
- Run by
- AOP Orphan Pharmaceuticals AG
See details and how to joinNCT06317805 · EU 2023-504351-26-01 - 3. fázisTaking peopleInvestigational Trial to Evaluate Safety and Tolerability of Treprostinil in Children Diagnosed With PAH
- Where
- Barcelona, Madrid
- Életkor
- Up to 18 év
- People
- 20 worldwide
- Run by
- AOP Orphan Pharmaceuticals AG
See details and how to joinNCT06350032 · EU 2023-505082-91-00 - No phaseCsak meghívásosA Prospective Non-interventional Observational Study to Observe Long-term Treatment and Outcomes in Pulmonary Arterial Hypertension (PAH) Patients
- Where
- Barcelona, Madrid
- Életkor
- 18 év and over
- People
- 110 worldwide
- Run by
- AOP Orphan Pharmaceuticals AG
See details and how to joinNCT06445673 - 2. fázisNot yet taking people in SpanyolországClinical Trial of NS-863 in Participants With Pulmonary Arterial Hypertension (PAH)
- Where
- Barcelona, Madrid, Palma, Santander, Toledo
- Életkor
- 18 év to 75 év
- People
- 135 worldwide
- Run by
- NS Pharma, Inc.
See details and how to joinNCT07441200 · EU 2025-525114-38-00 - 2. fázisTaking peopleStudy of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease
- Where
- Barcelona, Madrid, Santander
- Életkor
- 18 év to 80 év
- People
- 25 worldwide
- Run by
- Tectonic Operating Company, Inc.
See details and how to joinNCT07473700 - 3. fázisTaking peopleEfficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Where
- Barcelona, L'Hospitalet de Llobregat, Madrid, Majadahonda, Palma de Mallorca, Santiago de Compostela, Seville, Toledo
- Életkor
- 18 év and over
- People
- 344 worldwide
- Run by
- Insmed Incorporated
See details and how to joinNCT07179380 · EU 2025-521558-40-00 - 2. fázisTaking peopleStudy of REGN13335 in Adult Participants With Pulmonary Arterial Hypertension (PAH)
- Where
- Barcelona, Madrid, Marbella, Salamanca, Santander, Toledo
- Életkor
- 18 év and over
- People
- 99 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT07318597 · EU 2024-514754-79-00 - No phaseTaking peoplePulmonary Embolism Registry From Short-Term Emergency to Long-Term Follow-Up and Surveillance
- Where
- Madrid
- Életkor
- 18 év and over
- People
- 5000 worldwide
- Run by
- Azienda Ospedaliero-Universitaria Careggi
See details and how to joinNCT07855679 - 3. fázisTaking peopleA Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
- Where
- Barcelona, Santander
- Életkor
- 18 év to 80 év
- People
- 344 worldwide
- Run by
- Liquidia Technologies, Inc.
See details and how to joinNCT07285655 - 3. fázisFut, nem toborozOpen-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
- Where
- Barcelona, Madrid, Majadahonda, Marbella, Palma, Salamanca, Santander, Sevilla, Toledo, Valencia
- Életkor
- 18 év to 75 év
- People
- 330 worldwide
- Run by
- Gossamer Bio USA, Inc.
See details and how to joinNCT06274801 · EU 2023-506334-75-00 - 3. fázisNot yet taking people in SpanyolországA Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)
- Where
- Madrid, Málaga, Palma, Santander, Santiago de Compostela, Sevilla, Toledo, Vigo
- Életkor
- 18 év to 75 év
- People
- 344 worldwide
- Run by
- Insmed Incorporated
See details and how to joinNCT07481981 · EU 2026-525265-48-00 - 2. fázisTaking peopleA Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
- Where
- Madrid, Toledo
- Életkor
- 18 év to 80 év
- People
- 40 worldwide
- Run by
- AllRock Bio, Inc.
See details and how to joinNCT07175038 · EU 2025-522074-37-00 - 3. fázisFut, nem toborozA Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
- Where
- Barcelona, Madrid, Valencia
- Életkor
- 18 év and over
- People
- 1000 worldwide
- Run by
- United Therapeutics
See details and how to joinNCT03683186 · EU 2023-509305-68-00 - 3. fázisTaking peopleAn Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)
- Where
- Barcelona, Madrid, Málaga, Marbella Málaga, Salamanca, Santander, Sevilla, Toledo, Valencia
- Életkor
- 18 év to 75 év
- People
- 486 worldwide
- Run by
- Inhibikase Therapeutics
See details and how to joinNCT07365332 · EU 2024-520218-23-00 - No phaseNot yet taking people in SpanyolországTelerehabilitation in Pulmonary Arterial Hypertension
- Where
- Málaga
- Életkor
- 18 év and over
- People
- 34
- Run by
- Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud
See details and how to joinNCT07799675 - 1/2. fázisTaking peopleA Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
- Where
- Barcelona, Las Palmas de Gran C, Marbella, Santiago Compostela, Seville, Toledo
- Életkor
- 18 év to 100 év
- People
- 232 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06649110 - 3. fázisNot yet taking people in SpanyolországA Phase 3 Study of Extended-release Tacrolimus in Subjects With Pulmonary Arterial Hypertension and Functional Limitations
- Where
- Barcelona, Lugo, Madrid, Marbella, Toledo, Vigo
- Életkor
- 18 év to 75 év
- People
- 300 worldwide
- Run by
- VIVUS LLC
See details and how to joinNCT07612657 · EU 2025-524596-24-00 - No phaseTaking peopleEvaluation of the BMPR2-Activin Signaling Pathway in Group II Pulmonary Hypertension.
- Where
- Madrid
- Életkor
- 18 év and over
- People
- 150
- Run by
- Hospital General Universitario Gregorio Marañon
See details and how to joinNCT07537517